naftopidil has been researched along with tamsulosin in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.13) | 18.2507 |
| 2000's | 25 (53.19) | 29.6817 |
| 2010's | 19 (40.43) | 24.3611 |
| 2020's | 2 (4.26) | 2.80 |
| Authors | Studies |
|---|---|
| Li, MY; Tsai, KC; Xia, L | 1 |
| Asano, M; Honda, K; Inagaki, O; Kawabe, K; Kimura, R; Mori, R; Suzuki, M; Takenaka, T; Tanaka, C; Yamada, S | 1 |
| Arai, G; Hayashi, T; Hyochi, N; Kageyama, Y; Kawakami, S; Kihara, K; Kobayashi, T; Masuda, H; Okuno, T; Saito, K; Sakai, Y; Suzuki, M | 1 |
| Ashitomi, K; Hatano, T; Miyazato, M; Nishijima, S; Ogawa, Y; Sugaya, K | 1 |
| Abe, K; Goto, H; Ikemoto, I; Kishimoto, K; Kiyota, H; Miki, K; Ohishi, Y | 1 |
| Miyata, K; Ohtake, A; Saitoh, C; Sasamata, M; Sato, S; Yuyama, H | 1 |
| Gotoh, M; Kamihira, O; Kinukawa, T; Ohshima, S; Ono, Y; Origasa, H | 1 |
| Furuya, R; Furuya, S; Hisasue, S; Itoh, N; Masumori, N; Ogura, H; Tsukamoto, T | 1 |
| Morishima, S; Muramatsu, I; Suzuki, F; Tanaka, T; Yamamoto, H | 1 |
| Kawabe, K | 1 |
| Kobayashi, K; Kobayashi, M; Maruyama, I; Shibata, N; Tatemichi, S; Yamazaki, Y | 1 |
| Hayashi, M; Kobayashi, M; Kobayashi, S; Shibata, N; Tadachi, M; Tatemichi, S; Tomiyama, Y; Yamazaki, Y | 1 |
| Deguchi, T; Ishihara, S; Masue, T; Miwa, K; Nishino, Y; Takahashi, Y | 1 |
| Kobayashi, K; Kobayashi, M; Kobayashi, S; Maezawa, A; Maruyama, I; Shibata, N; Tatemichi, S; Tomiyama, Y; Yamazaki, Y | 1 |
| Furuya, R; Furuya, S; Hisasue, S; Itoh, N; Kobayashi, K; Tsukamoto, T | 1 |
| Fujita, Y; Inamura, M; Koyama, T; Miyoshi, T; Ohashi, Y; Ohki, K; Okamoto, S; Oshika, T; Sakabe, I; Takahashi, K; Yasuma, T | 1 |
| Hosokawa, Y; Kishino, T; Momose, H; Ono, T; Oyama, N | 1 |
| Abe, K; Egaway, S; Furuta, A; Ikemoto, I; Kishimoto, K; Kiyota, H; Kosugi, S; Shimomura, T; Shirai, H; Suzuki, Y; Takeuchi, H; Torii, S | 1 |
| Jin, J; Kong, CZ; Li, NC; Na, YQ; Qiu, SP; Song, YS; Sun, G; Sun, YC; Sun, YH; Wang, XF; Wu, SL; Ye, ZQ | 1 |
| Noguchi, Y; Ohtake, A; Sasamata, M; Suzuki, M | 1 |
| Hayase, M; Hayashi, Y; Kohri, K; Kojima, Y; Kubota, Y; Sasaki, S; Shinoura, H; Tsujimoto, G | 1 |
| Oh-oka, H | 1 |
| Aizawa, N; Andersson, KE; Chen, Z; Igawa, Y; Imamura, T; Ishizuka, O; Nishizawa, O | 1 |
| Fujihara, A; Kamoi, K; Kanazawa, M; Miki, T; Okihara, K; Ukimura, O | 1 |
| Furuya, R; Iwasawa, A; Masumori, N; Mori, M; Sonoda, T; Tsukamoto, T | 1 |
| Fink, HA; Garimella, PS; Macdonald, R; Wilt, TJ | 1 |
| Honda, S; Iwata, S; Kawachi, Y; Maruyama, O; Noto, K; Sakurai, T; Sugimura, S | 1 |
| Hikima, N; Horiuchi, K; Kondo, Y; Ohgaki, K | 1 |
| Hanyu, S; Hatano, A; Nishiyama, T; Obara, K; Takahashi, K | 1 |
| Fujii, T; Fukumoto, K; Hara, R; Jo, Y; Miyaji, Y; Nagai, A; Sone, A; Yokoyama, T | 1 |
| Baba, S; Fujita, T; Hayakawa, K; Ishiyama, H; Kimura, M; Kitano, M; Kotani, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H | 1 |
| Hui, JH; Lu, JL; Zhou, SG | 1 |
| Hoyano, Y; Kobayashi, K; Kobayashi, M; Kuroda, J; Kusama, H; Maruyama, K; Tatemichi, S; Yokoi, R | 1 |
| Liu, Y; Mao, C; Qin, X; Yang, K; Yang, Z; Yuan, J | 1 |
| Enomoto, Y; Fujimura, T; Fukuhara, H; Hirano, Y; Homma, Y; Kumano, S; Kume, H; Nishimatsu, H; Suzuki, M; Yamada, D | 1 |
| Araki, M; Araki, T; Monden, K | 1 |
| Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P | 1 |
| Ito, N; Kamiyama, Y; Kanamaru, S; Kawakita, M; Matsumoto, K; Muguruma, K; Shirahase, T; Takahashi, T; Tsukazaki, H; Tsunemori, H; Utsunomiya, N | 1 |
| Gao, L; Li, J; Qin, F; Tang, Z; Yuan, J | 1 |
| Chung, JI; Hong, JH; Jung, TY; Kang, TW; Kwak, C; Kwon, SY; Lee, JY; Lee, KS; Seo, SI; Yoo, TK; Yun, SJ | 1 |
| Haga, K; Hirose, T; Ichihara, K; Iwasawa, A; Masumori, N; Miyao, N; Nishimura, M; Sasamura, H; Suzuki, N; Taguchi, K; Yamaguchi, Y | 1 |
| Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R | 1 |
| Kubono, S; Kuramoto, K; Mizutani, H; Takahashi, H; Tanaka, N; Taneyama, T; Yoshida, M | 1 |
| Fujimura, M; Fukui, T; Oka, M; Oyama, T; Yoshifuji, M; Yoshinaga, R | 1 |
| Miernik, A; Praus, F | 1 |
| Chai, Y; Che, X; Cui, Y; Zhang, Y; Zhou, Z | 1 |
| Kawakami, Y; Kotake, K; Noritake, Y | 1 |
9 review(s) available for naftopidil and tamsulosin
| Article | Year |
|---|---|
[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Amino Acid Sequence; Animals; Cloning, Molecular; Drug Design; Drug Tolerance; Humans; Male; Molecular Sequence Data; Naphthalenes; Piperazines; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethral Obstruction | 2006 |
[Latest frontiers in pharmacotherapy for benign prostatic hyperplasia].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Design; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Naphthalenes; Piperazines; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethral Obstruction | 2006 |
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Prostatism; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin | 2009 |
The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews.
Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2013 |
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics | 2016 |
Efficacy and Safety of Naftopidil in the Medical Expulsion Therapy for Distal Ureteral Stone: A Systematic Review and Meta-Analysis.
Topics: Adrenergic alpha-Antagonists; Cost-Benefit Analysis; Female; Humans; Male; Naphthalenes; Odds Ratio; Patient Safety; Piperazines; Randomized Controlled Trials as Topic; Risk Assessment; Sulfonamides; Tamsulosin; Treatment Outcome; Ureteral Calculi | 2017 |
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms].
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Tamsulosin; Treatment Outcome; Urological Agents | 2019 |
Outcomes and complications of naftopidil versus tamsulosin for elderly men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review and meta-analysis.
Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome | 2021 |
18 trial(s) available for naftopidil and tamsulosin
| Article | Year |
|---|---|
[A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin | 2002 |
Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover study.
Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Dizziness; Headache; Humans; Hypotension, Orthostatic; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders | 2003 |
Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial.
Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Humans; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Urodynamics | 2005 |
Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics | 2006 |
Crossover comparison study on the therapeutic effects of tamsulosin hydrochloride and naftopidil in lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Drug Therapy, Combination; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders | 2007 |
[Comparison of different drugs on the treatment of benign prostate hyperplasia].
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androstadienes; Double-Blind Method; Doxazosin; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Plant Extracts; Prazosin; Prostate; Prostatic Hyperplasia; Quality of Life; Secale; Sulfonamides; Tamsulosin; Treatment Outcome | 2007 |
Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Biopsy; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; RNA, Messenger; Sulfonamides; Tamsulosin; Treatment Outcome | 2008 |
Effect of naftopidil on nocturia after failure of tamsulosin.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Quality of Life; Retreatment; Sulfonamides; Tamsulosin; Treatment Failure | 2008 |
Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study.
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2008 |
Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study.
Topics: Adrenergic alpha-Antagonists; Aged; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2009 |
Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Drug Therapy, Combination; Humans; Middle Aged; Multivariate Analysis; Naphthalenes; Parasympatholytics; Phytotherapy; Piperazines; Plant Preparations; Propiophenones; Proportional Hazards Models; Quercus; Radiography; Sulfonamides; Tamsulosin; Ultrasonography; Ureteral Calculi | 2010 |
[A randomized controlled study comparing clinical effects of naftopidil and tamsulosin on benign prostatic hyperplasia].
Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urination | 2010 |
Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Ejaculation; Erectile Dysfunction; Humans; Indoles; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Piperazines; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination; Urination Disorders | 2011 |
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Brachytherapy; Humans; Indoles; Iodine Radioisotopes; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Sulfonamides; Tamsulosin | 2011 |
Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones.
Topics: Adrenergic alpha-Antagonists; Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Naphthalenes; Piperazines; Prospective Studies; Receptors, Adrenergic, alpha-1; Retrospective Studies; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Ultrasonography; Ureteral Calculi | 2011 |
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2013 |
[A Crossover Comparison Study on Lower Urinary Tract Symptoms with Overactive Bladder Secondary to Benign Prostatic Hyperplasia: Naftopidil versus Tamsulosin with Solifenacin].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive | 2016 |
Comparison of the Effect of Naftopidil 75 mg and Tamsulosin 0.2 mg on the Bladder Storage Symptom With Benign Prostatic Hyperplasia: Prospective, Multi-institutional Study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Humans; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome; Urinary Bladder; Urinary Bladder Diseases | 2018 |
20 other study(ies) available for naftopidil and tamsulosin
| Article | Year |
|---|---|
Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Evaluation, Preclinical; Expert Systems; Humans; Models, Molecular; Receptors, Adrenergic, alpha-1; Software; Structure-Activity Relationship | 2005 |
Comparative study on alpha 1-adrenoceptor antagonist binding in human prostate and aorta.
Topics: Adrenergic alpha-Antagonists; Aged; Aorta; Binding Sites; Binding, Competitive; Clonidine; Dose-Response Relationship, Drug; Humans; Kinetics; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostate; Sulfonamides; Tamsulosin | 1994 |
Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Efferent Pathways; Female; Hypogastric Plexus; Injections, Spinal; Male; Muscle Contraction; Muscle, Smooth; Naphthalenes; Parasympathetic Nervous System; Piperazines; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Spinal Cord; Sulfonamides; Tamsulosin; Urinary Bladder | 2002 |
Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Dogs; Female; Hypogastric Plexus; Male; Naphthalenes; Piperazines; Prazosin; Pressure; Sex Factors; Sulfonamides; Tamsulosin; Urethra | 2004 |
[Ejaculatory disorder by alpha-1 adrenoceptor antagonist in patients with benign prostatic hyperplasia; retrospective comparison between naftopidil and tamsulosin].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Retrospective Studies; Sexual Dysfunctions, Psychological; Sulfonamides; Tamsulosin | 2005 |
[Effects of silodosin (KMD-3213) on phenylephrine-induced increase in intraurethral pressure and blood pressure in rats--study of the selectivity for lower urinary tract].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Indoles; Male; Naphthalenes; Phenylephrine; Piperazines; Prazosin; Pressure; Rats; Sulfonamides; Tamsulosin; Urethra | 2006 |
[Effect of silodosin on intraurethral pressure increase induced by hypogastric nerve stimulation in dogs with benign prostatic hyperplasia].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Hypogastric Plexus; Indoles; Male; Naphthalenes; Piperazines; Pressure; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethra | 2006 |
Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Carotid Artery, Common; Data Interpretation, Statistical; Dogs; Electric Stimulation; Heart Rate; Hypogastric Plexus; In Vitro Techniques; Indoles; Male; Naphthalenes; Norepinephrine; Organ Specificity; Piperazines; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethra; Urethral Obstruction; Urinary Tract | 2006 |
Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Ejaculation; Follow-Up Studies; Gene Expression; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Semen; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin | 2006 |
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist.
Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Female; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2007 |
[A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia with overactive bladder].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive | 2007 |
In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Ejaculation; Indoles; Male; Naphthalenes; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin; Urethra; Vas Deferens | 2008 |
Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Body Temperature; Cold Temperature; Female; Indoles; Naphthalenes; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urinary Bladder; Urinary Bladder, Overactive | 2009 |
Long-term treatment and prognostic factors of alpha 1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: a pilot study comparing naftopidil and tamsulosin hydrochloride.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Naphthalenes; Pilot Projects; Piperazines; Prognosis; Prostatic Hyperplasia; Prostatism; Retrospective Studies; Sulfonamides; Tamsulosin; Time Factors | 2010 |
Comparison of the effects of four α1-adrenoceptor antagonists on ejaculatory function in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Ejaculation; Indoles; Male; Naphthalenes; Piperazines; Quinazolines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin | 2012 |
Reduction of prostate cancer incidence by naftopidil, an α1 -adrenoceptor antagonist and transforming growth factor-β signaling inhibitor.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Apoptosis; Cell Line, Tumor; HeLa Cells; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Naphthalenes; Piperazines; Proportional Hazards Models; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Signal Transduction; Sulfonamides; Tamsulosin; Transforming Growth Factor beta | 2013 |
Silodosin as second-line α-blocker monotherapy in patients with benign prostatic hyperplasia: A prospective observational study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Tamsulosin; Treatment Outcome | 2018 |
Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Epidemiological Monitoring; Humans; Indoles; Japan; Male; Middle Aged; Naphthalenes; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Surveys and Questionnaires; Tamsulosin; Treatment Outcome | 2019 |
Comparison of the Effects of Tadalafil and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Ejaculation; Electric Stimulation; Indoles; Male; Muscle Contraction; Naphthalenes; Phosphodiesterase 5 Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Seminal Vesicles; Tadalafil; Tamsulosin; Vas Deferens | 2019 |
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan.
Topics: Adrenergic Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cholinergic Antagonists; Delirium; Humans; Japan; Male; Pharmacovigilance; Prostatic Hyperplasia; Tamsulosin | 2023 |